There are no reports involved the intestinal microbiota from Chinese infants with short bowel syndrome (SBS) under different clinical status. Alterations in the microbiota are closely correlated with the bile acids and short chain fatty acids metabolism as well as the intestinal immunity. A relatively comprehensive profile composed of microbial structure, microbial metabolism products and immune biomarkers in SBS infants may facilitate a better therapy strategy to complications occurred in SBS children.
The investigators totally collected 26 fecal samples from 18 infants diagnosed with SBS during parenteral nutrition administration, and these samples were divided into three groups according to complications of enrolled patients at sampling time: asymptomatic group, central catheter-related blood stream infections group and liver injury group. 7 healthy infants with supplementary food were enrolled as control. Fecal microbiota, sIgA and calprotectin, bile acids and short chain fatty acids were also detected by 16S ribosomal ribonucleic acid (rRNA) gene sequencing, enzyme-linked immunosorbent assay and liquid/gas chromatography.
Study Type
OBSERVATIONAL
Enrollment
33
Not involved
Ethics Committee of Xinhua Hospital
Shanghai, Shanghai Municipality, China
Microbial structure in SBS infants
Fecal microbiota were detected by 16S rRNA gene sequencing.
Time frame: up to 4 months
Metabolism products in SBS infants
Bile acids and short chain fatty acids were detected by liquid/gas chromatography.
Time frame: up to 4 months
Immune biomarkers in SBS infants
Secretary IgA and calprotectin were detected by enzyme-linked immunosorbent assay.
Time frame: up to 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.